To evaluate the efficacy and safety of MOD-4023 compared to Placebo

• Research type

  Research Study

• Full title

  A PHASE 3, MULTICENTER STUDY DESIGNED TO EVALUATE THE EFFICACY AND SAFETY OF A LONG ACTING HGH PRODUCT (MOD-4023) IN ADULT SUBJECTS WITH GROWTH HORMONE DEFICIENCY

• IRAS ID

  130628

• Contact name

  Simon Aylwin

• Contact email

  simonaylwin@nhs.net

• Sponsor organisation

  OPKO Biologics Ltd

• Eudract number

  2013-000830-37

• ISRCTN Number

  not provided

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  13/LO/1127

• Date of REC Opinion

  30 Sep 2013

• REC opinion

  Further Information Favourable Opinion